Effects of pH and urea on the determination of urinary myoglobin concentration by an enzyme immunoassay

Clinica Chimica Acta

Volumn 282, Issue 1-2, 1999, Pages 203-209

  Kitao, Takashi ^a,b   Miyaishi, Satoru ^a   Ishizu, Hideo ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b EHIME PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Enzyme immunoassay; Myoglobin; pH; Urea

Indexed keywords

MYOGLOBIN; UREA;

ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN TISSUE; NORMAL HUMAN; PH; PRIORITY JOURNAL; PROTEIN DETERMINATION; TECHNIQUE; URINALYSIS;

ANIMALS; CRYOPRESERVATION; GOATS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOENZYME TECHNIQUES; MYOGLOBIN; MYOGLOBINURIA; RABBITS; SPECIMEN HANDLING; TEMPERATURE; UREA;

EID: 0032948365     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00011-X     Document Type: Article

References (14)

1. Perkoff G.T., Hill R.L., Brown D.M., Tyler F.H. The characterization of adult human myoglobin. J Biol Chem. 237:(9):1962;2820-2827.
2. Kendrew J.C., Bodo G., Dintzis H.M., Parrish R.G., Wyckoff L.I. A three-dimensional model of the myoglobin molecule obtained by X-ray analysis. Nature. 181:1958;662-666.
3. Perkoff G.T. Studies of human myoglobin in several diseased of muscle. New Engl J Med. 270:(6):1964;263-269.
4. Kagen J.L. Myoglobinemia and myoglobinuria in patients with myositis. Arthritis Rheum. 14:(4):1971;457-464.
5. Grenadier E., Keidar S., Kahana L., Alpan G., Marmur A., Palant A. The roles of serum myoglobin, total CPK and CK-MB isoenzyme in the acute phase of myocardial infarction. Am Heart J. 105:1983;408-416.
6. Drexel H., Dworzak E., Kirchmair W., Milz M.M., Puschendorf B., Dienstl F. Myoglobinemia in the early phase of acute myocardial infarction. Am Heart J. 105:1983;642-651.
7. Veerkamp J.H., Smit J.W.A., Benders A.A.G.M., Oosterhof A. Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cell. Biochim Biophys Acta. 1315:1996;217-222.
8. Flint O.P., Masters B.A., Gregg R.E., Durham S.K. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture. Toxicol Appl Pharmacol. 145:1997;99-110.
9. Wu A.B., Laios I., Green S., Gornet T.G., Wong S.S., Parmley L., Tonnesen A.S., Plaisier B., Orlando R. Immunoassays for Serum and Urine Myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem. 40:(5):1994;796-802.
10. Loun B., Astles R., Copeland K.R., Sedor F.A. Adaptation of a quantitative immunoassay for urine myoglobin. Am J Clin Pathol. 105:1996;479-486.
11. Copel K.R., Loun B., Sedor F.A. Stability of control material suitable for quantitative measurement of urine myoglobin. Clin Chem. 43:(11):1997;2202-2204.
12. Miyaishi S. An enzyme immunoassay for human myoglobin and its application to forensic medicine. Jpn J Legal Med. 45:(1):1991;6-25.
13. 2-Microglobulin in urine: not suitable for assessing renal tubular function. Clin Chem. 29:(5):1983;996-997.
14. Hodson A.W., Skillen A.W., Argent N.B. An ELISA method to measure human myoglobin in urine. Clin Chim Acta. 209:1992;197-207.